Jan 11, 2018
867:776
For every 776 shares held, investors received 867. The price per share adjusted from $127.50 to $114.12.
The split itself did not change the total investment value.
Infant Bacterial Therapeutics AB Class B (STO:IBT_B) operates in the Pharmaceuticals: major industry.
Infant Bacterial Therapeutics AB Class B company overviewInfant Bacterial Therapeutics AB Class B's most recent stock split was on January 11, 2018. It was a 867-for-776 forward split, so shareholders received 867 shares for every 776 they held.
Infant Bacterial Therapeutics AB Class B (STO:IBT_B) has split its stock 2 times: a 75-for-46 split on May 3, 2016 and a 867-for-776 split on January 11, 2018.
Infant Bacterial Therapeutics AB Class B has split its stock 2 times. This history records 2 forward splits between May 3, 2016 and January 11, 2018.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Infant Bacterial Therapeutics AB Class B's 867-for-776 split on January 11, 2018, every 776 shares became 867 shares.
Infant Bacterial Therapeutics AB Class B has not announced a new split in our records. Its most recent split was on January 11, 2018, 8 years ago. Companies announce splits in advance, and any new STO:IBT_B split will appear on this page.
Already premium?